These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8207686)

  • 1. Pharmacokinetics, safety, and tolerability of flosequinan in patients with hepatic dysfunction.
    Hinson JL; Hind ID; Weidler DJ
    J Pharm Sci; 1994 Mar; 83(3):382-5. PubMed ID: 8207686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of flosequinan in patients with compromised renal function.
    Gallo BV; Hinson JL; Weidler DJ
    J Pharm Sci; 1993 Mar; 82(3):282-5. PubMed ID: 8450423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of flosequinan in patients with heart failure.
    Nicholls DP; Droogan A; Carson CA; Taylor IC; Passmore AP; Johnston GD; Kendall M; Dutka D; Morris GK; Underwood LM; Hind ID
    Eur J Clin Pharmacol; 1996; 50(4):289-91. PubMed ID: 8803521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
    Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of OPC-8212 in humans: a new, nonglycosidic, inotropic agent.
    Ohnishi A; Ishizaki T
    J Clin Pharmacol; 1988 Aug; 28(8):719-26. PubMed ID: 3216039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
    Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of two oral formulations of triflusal capsules in healthy volunteers.
    Quetglas EG; Campanero MA; Sádaba B; Escolar M; Azanza JR
    Arzneimittelforschung; 2008; 58(6):283-7. PubMed ID: 18677970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of concurrent administration of flosequinan and digoxin on the pharmacokinetics of each drug.
    Rau R; Hind ID; Wynne RD; White SA
    Arzneimittelforschung; 1994 Mar; 44(3):300-4. PubMed ID: 8192694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hepatic impairment on lenvatinib pharmacokinetics following single-dose oral administration.
    Shumaker R; Aluri J; Fan J; Martinez G; Pentikis H; Ren M
    J Clin Pharmacol; 2015 Mar; 55(3):317-27. PubMed ID: 25204557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and urine pharmacokinetics of the dopamine agonist alpha-dihydroergocryptine in patients with hepatic dysfunction.
    Althaus M; de Mey C; Ezan E; Ciecko-Michalska ; Kostka-Trabka E; Goszcz A; Retzow A
    Int J Clin Pharmacol Ther; 2001 Feb; 39(2):67-74. PubMed ID: 11270804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of flosequinan in elderly patients with chronic congestive heart failure.
    Sakai M; Ohkawa S; Kaku T; Kuboki K; Chida K; Imai T
    Eur J Clin Pharmacol; 1993; 44(4):387-9. PubMed ID: 8513852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers.
    Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of montelukast tablets in healthy Pakistani volunteers.
    Abbas M; Khan AM; Amin S; Riffat S; Ashraf M; Waheed N
    Pak J Pharm Sci; 2013 Mar; 26(2):255-9. PubMed ID: 23455193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific and simultaneous high-performance liquid chromatographic assay of flosequinan and its metabolites in human plasma.
    Kashiyama E; Odomi M; Shimizu T
    J Chromatogr; 1994 Feb; 652(2):179-85. PubMed ID: 8006102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers.
    Zhao Q; Iyer GR; Verhaeghe T; Truyen L
    J Clin Pharmacol; 2002 Apr; 42(4):428-36. PubMed ID: 11936568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous modelling of flosequinan and its metabolite.
    Lindsey JK; Wang J; Jones B; Byrom WD; Hind ID
    Eur J Clin Pharmacol; 2000; 55(11-12):827-36. PubMed ID: 10805061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.